Skip to main content

National Biomedical Resource for
Advanced ESR Spectroscopy

      ACERT's Service and Collaborative Projects


Diphthamide biosynthesis requires a SAM-dependent [4Fe-4S]-containing enzyme

Diphthamide is a posttranslationally modified His residue in eukaryotic translation elongation factor 2 (EF-2), a GTPase required for the translocation step of ribosomal protein synthesis. The name "diphthamide" comes from diphtheria toxin, which specifically ADP-ribosylates this posttranslational modification, inhibits protein synthesis and leads to host cell death. Understanding how diphthamide is synthesized and how the biosynthesis is regulated will provide useful insights into its biological function. One of the most intriguing facts about diphthamide is that Dph1, one of the genes involved in the biosynthesis, is found to be a tumor suppressor gene in humans. Loss of a Dph1 gene is observed in 80% of ovarian cancers as well as in other types of cancers, such as breast, lung and brain malignancies. Here we present structural and biochemical evidence showing that the first step of diphthamide biosynthesis in archaea uses a novel iron-sulfur cluster enzyme, Dph2. Dph2 is a homodimer and each monomer contains a [4Fe-4S] cluster. Biochemical data suggest that unlike known radical SAM enzymes, Dph2 does not form 5´-deoxyadenosyl radicals. Instead, it breaks the other C-S bond of SAM and transfers the 3-amino-3-carboxylpropyl group to EF-2, possibly via a radical mechanism. This work suggests that archaeal Dph2 represents a novel radical SAM enzyme with a three-dimensional structure different from known radical SAM enzymes and catalyzes unprecedented chemistry. In this study ESR spectroscopy provided important evidence for the existence of the iron-sulfur cluster and changes in its oxidation state. PhDph2 as purified has essentially no EPR signal, indicative of a [4Fe-4S]2+ state. Upon reduction with dithionite, the protein has a strong EPR signal. The g- and the temperature-dependence are typical of a [4Fe-4S] ]+ cluster. Quantification of the EPR spectrum suggests the presence of 0.3 [4Fe-4S] ]+ per PhDph2:

Publication: Y. Zhang, X. Zhu, A. Torelli, M. Lee, B. Dzikovski, R.M. Koralewski, E. Wang, J.H. Freed, C. Krebs, S.E. Ealick, and H. Lin, Nature, 465, 891-896 (2010); PMC3006227

The oxidized form of PhDph2 shows a fraction (~0.08) with a narrow ESR signal having an average g-factor of ~2.01 indicative of a [3Fe-4S]+ cluster. In further studies ESR has helped to prove the involvement of specific cysteines in cluster ligation.

Yang Zhang, Xuling Zhu, Andrew Torelli (Department of Chemistry and Chemical Biology, Cornell University)
Michael Lee (Department of Biochemistry and Molecular Biology, Pennsylvania State University)
Boris Dzikovski, Rachel M. Koralewski, Eileen Wang, Jack H. Freed (Department of Chemistry and Chemical Biology, Cornell University)
Carsten Krebs (Department of Biochemistry and Molecular Biology and Department of Chemistry, Pennsylvania State University)
Steven E. Ealick, Hening Lin (Department of Chemistry and Chemical Biology, Cornell University)

© 2022   

 


Site Map

Home

About ACERT
   ACERT News
   Personnel

Contact Us
   Software Portal at Signal Science Lab
   Laboratory Service Request Portal
   To Acknowledge ACERT
 

Research
   Available Resources
   Technologies
   Research Highlights
   Collaborations

Outreach
   Dissemination
   Training/Workshops
   Publications
   Useful Links

ACERT is supported by grant 1R24GM146107 from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health.

 


National Biomedical Resource for Advanced ESR Spectroscopy

Baker Laboratory of Chemistry
259 East Ave.
Ithaca, NY 14853


National Institute of
General Medical Sciences